Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
Izmir Bakircay University
Baylor College of Medicine
University of California, San Francisco